Pure play third party contract manufacturing

Pure play third party contract manufacturing

Committed to the Health Care Industry to improve the wellbeing of patients

Committed to the Health Care Industry to improve the wellbeing of patients

Focused in developing and manufacturing small molecule intermediates and active ingredients

Focused in developing and manufacturing small molecule intermediates and active ingredients

4 cGMP sites, strategically distributed across the globe

4 cGMP sites across the globe      

Tailor-made Contract Manufacturing solutions for the healthcare industry

Key facts

1.065
Employees
 

5
Factories
in 3 continents

€285 M
In revenues in 2021
 

22
Therapeutic areas diversification
of commercial products

1.035 m3
Reaction capacity
 

>100,000h
Devoted to R&D
projects in 2021

56
Years from our
foundation
 

+20
NCE customer product
filings since 2007
 

56
Active projects for 28 customers
during 2021
 

News & events